MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) Chief Executive Officer Shankar Musunuri will discuss regulatory approval and commercialization of cell and gene therapies at an industry conference Oct. 6 in …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.